Suppression of thromboxane levels by percutaneous...

Details Suppression of thromboxane levels by percutaneous... Suppression of thromboxane levels by percutaneous...

A - Human Necessities

61

K

A61K 31/60 (2006.01) A61K 9/00 (2006.01) A61K 9/70 (2006.01)

Patent

CA 2107587

A method is disclosed for inducing thromboxane suppression in a mammalian subject by percutaneously administering a pharmaceutical composition containing aspirin. Articles useful for practicing the therapeutic methods of the invention are also disclosed.

Affiliated with

Also associated with

Rating

Suppression of thromboxane levels by percutaneous... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Suppression of thromboxane levels by percutaneous..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Suppression of thromboxane levels by percutaneous... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1557583